Clinical Study
The Experience in Nicaragua: Childhood Leukemia in Low Income Countries—The Main Cause of Late Diagnosis May Be “Medical Delay”
Table 2
Medical assessments performed before diagnosing leukemia and clinical condition at the diagnosis.
| | Managua | Monza | value |
| Number of medical evaluations before diagnosis | | | | Median, (IQR) | 3 (2–4) | 2 (2-3) | # |
| Clinical conditions at admission (frequencies) | | | | Good | 52 (64.2%) | 71 (87.7%) |
°
| Poor | 29 (35.8%) | 10 (12.3%) |
| Type of first medical evaluation before diagnosis (frequencies) | | | | First | 51 (63%) | 57 (70.4%) |
°
| Second | 29 (35.8%) | 23 (28.4%) |
°
| Third | 1 (1.2%) | 1 (1.2%) | • |
| Antibiotics treatment before diagnosis (frequencies) | | | | Yes | 48 (59%) | 35 (43%) |
°
| No | 33 (41%) | 46 (57%) |
| Iron supplementation before diagnosis (frequencies) | | | | Yes | 16 (20%) | 0 (0%) | • | No | 65 (80%) | 81 (100%) |
|
|
°
: Chi-square test; •: Fisher Test; #: Mann-Whitney/Wilcoxon Two-Sample Test.
|